USPTO serial 79431868
SEQITOPE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 16, 2026
- Examiner
- FERRELL, LUCY K
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEQITOPE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific research, development, engineering, laboratory, and testing services in the field of biochemistry and biotechnology; research, development, engineering, testing, consulting, and analytical services for analysing and quantifying the diversity of the immune system and immune system therapeutics; research, development, engineering, testing, consulting, and analytical services for discovering immune targets in the field of medical research; research, engineering, testing, consulting, and analytical services for epitope mapping; providing sequencing data and analysis of the immune system for vaccine development and vaccine optimisation; research and development of antibodies, therapeutics, vaccines, immunotherapies, and diagnostics; research services in the field of immune repertoire analysis, personalised medicine, vaccines, immunotherapies, and diagnostics being diagnostic preparations and related consultation services; providing computational analysis of the immune repertoire; research, development, engineering, testing, consulting, laboratory, and analytical services in the field of drug discovery and drug screening; scientific and technological services, namely, scientific research, analysis and testing in the field of biochemistry and biotechnology and research and design relating thereto; industrial analysis and research services in the field of biochemistry and biotechnology; design and development of computer hardware and software. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 16, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 28, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 28, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 23, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 22, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 8, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 8, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 30, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 27, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 27, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 27, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 22, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 8, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 8, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 2, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 1, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 1, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 8, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 8, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 4, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |